These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4780002)

  • 41. A study on the relationship of porphyria cutanea tarda and liver damage.
    Horkay I; Prékopa A; Dalmy L; Dán S; Tamási P
    Arch Dermatol Forsch; 1973 Sep; 247(3):235-43. PubMed ID: 4748769
    [No Abstract]   [Full Text] [Related]  

  • 42. Phlebotomy and iron-overload in porphyria cutanea tarda.
    Kalivas JT; Pathak MA; Fitzpatrick TB
    Lancet; 1969 Jun; 1(7607):1184-7. PubMed ID: 4181840
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical value of serum gamma-glutamyl transferase estimation in porphyria cutanea tarda.
    Adjarov D; Ivanov E
    Br J Dermatol; 1980 May; 102(5):541-3. PubMed ID: 6104505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phlebotomy for porphyria cutanea tarda.
    JAMA; 1969 Feb; 207(6):1142. PubMed ID: 5818250
    [No Abstract]   [Full Text] [Related]  

  • 45. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
    Felsher BF; Jones ML; Redeker AG
    JAMA; 1973 Nov; 226(6):663-5. PubMed ID: 4800611
    [No Abstract]   [Full Text] [Related]  

  • 46. The porphyrias.
    Sekula SA; Tschen JA; Rosen T
    Am Fam Physician; 1986 Mar; 33(3):219-32. PubMed ID: 3513498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection.
    Ratnaike S; Blake D; Campbell D; Cowen P; Varigos G
    Australas J Dermatol; 1988 Apr; 29(1):3-8. PubMed ID: 3250437
    [No Abstract]   [Full Text] [Related]  

  • 48. [Biochemistry of the regression and latent phase of porphyria cutanea tarda].
    Peschlow I; Schlenzka K
    Dermatol Monatsschr; 1983 Feb; 169(2):85-91. PubMed ID: 6840368
    [No Abstract]   [Full Text] [Related]  

  • 49. Porphyria cutanea tarda: role of iron.
    Sachson RA
    N Engl J Med; 1969 Feb; 280(7):387. PubMed ID: 5762593
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda.
    Lundvall O
    Acta Med Scand; 1971; 189(1-2):51-63. PubMed ID: 5166124
    [No Abstract]   [Full Text] [Related]  

  • 51. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda.
    Rocchi E; Cassanelli M; Borghi A; Paolillo F; Pradelli M; Pellizzardi S; Vezzosi A; Gallo E; Baccarani Contri M; Ventura E
    Dermatologica; 1991; 182(1):27-31. PubMed ID: 2013352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda.
    Lundvall O; Weinfeld A
    Acta Med Scand; 1968 Sep; 184(3):191-9. PubMed ID: 5703974
    [No Abstract]   [Full Text] [Related]  

  • 54. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
    Walsh JR; Lobitz WC; Mahler DJ; Kingery FA
    Arch Dermatol; 1970 Feb; 101(2):167-72. PubMed ID: 5413253
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical trial of the treatment of porphyria cutanea tarda by plasmapheresis].
    Gasior-Chrzan B; Wasik F; Partyka T; Gamin E
    Przegl Dermatol; 1985; 72(3):294-7. PubMed ID: 3909235
    [No Abstract]   [Full Text] [Related]  

  • 57. [Porphyria cutanea tarda--introduction, diagnostic and therapeutic aspects].
    Wewalka F
    Wien Z Inn Med; 1966 Nov; 47(11):431-8. PubMed ID: 4900668
    [No Abstract]   [Full Text] [Related]  

  • 58. [Possible side effect of hormonal contraception: porphyria cutanea tarda].
    Zaumseil RP; Fiedler H
    Zentralbl Gynakol; 1983; 105(8):527-31. PubMed ID: 6868877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryoglobulinemia and porphyria hepatica chronica (porphyria cutanea tarda).
    Biró I; Káldor I; Török E; Vereczkei I; Biró I
    Acta Derm Venereol; 1964; 44(3):226-7. PubMed ID: 4165237
    [No Abstract]   [Full Text] [Related]  

  • 60. [Porphyria cutanea tarda].
    Wiedmann A
    Dermatol Int; 1965; 4(3):201-4. PubMed ID: 5877291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.